Volume 18, Number 9—September 2012
Letter
blaOXA-181–positive Klebsiella pneumoniae, Singapore
Table
Antimicrobial drug susceptibilities of 3 blaOXA-181–positive Klebsiella pneumoniae isolates, Singapore*
Drug | MIC (mg/L) |
||
---|---|---|---|
DB53879_11 | DX1083_11 | BL21479_11 | |
Ampicillin | ≥256 | ≥256 | ≥256 |
Amoxicillin/clavulanate | ≥256 | ≥256 | ≥256 |
Piperacillin/tazobactam | ≥256 | ≥256 | ≥256 |
Cefuroxime | ≥256 | ≥256 | ≥256 |
Ceftriaxone | ≥32 | ≥32 | ≥32 |
Ceftazidime | ≥256 | ≥256 | ≥256 |
Cefepime | ≥256 | ≥256 | ≥256 |
Ertapenem | ≥32 | ≥32 | ≥32 |
Imipenem | 16 | ≥32 | 16 |
Meropenem | ≥32 | ≥32 | ≥32 |
Doripenem | ≥32 | ≥32 | ≥32 |
Ciprofloxacin | ≥32 | ≥32 | ≥32 |
Levofloxacin | ≥32 | ≥32 | ≥32 |
Gentamicin | ≥256 | ≥256 | ≥256 |
Amikacin | ≥256 | ≥256 | ≥256 |
Sulfamethoxazole/trimethoprim | ≥32 | ≥32 | ≥32 |
Tetracycine | ≥256 | ≥256 | 8 |
Tigecycline | 4 | 4 | 4 |
Polymyxin B | 0.5 | 1 | 4 |
*OXA-181, oxacillinase-181.